Login
Home / 603520.SS : SHH
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Zhejiang Starry Pharmaceutical Co.,Ltd.

¥8.3 -$1.50 (-15.31%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥8.36
Day Range
¥8.3¥8.41
Year Range
¥7.89¥14.37
Market Cap
3.64B
AVG Volume
23.6M
Trailing/Forward PE
173.28/13.61
PEG ratio
1.57
Dividend Yield
3.61%
Next Earnings Date
2026-10-29
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
-60M-40M-20M020M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
-400M-200M0200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
-0.2-0.100.124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
0100M200M300MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
01B2B3B4BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-3%-2%-1%0%1%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.20.40.6Jun 19Jun 20Jun 21Jun 22Jun 23Sep 24Jun 25Sep 25Jun 26Sep 26
Book Value Per Share (CNY)
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
0200400600med 124.03Dec 22Apr 24Jul 24Nov 24Feb 25Jun 26Sep 26
Free Cash Flow Yield
-15%-10%-5%0%med -5.54%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
11.522.5med 1.76Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
1520253035med 22.97Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
0500100015002000med 16.42Jun 24Oct 24Apr 25Aug 25Nov 25Mar 26Jun 26
Price to Book
0.511.522.5med 1.61Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Zhejiang Starry Pharmaceutical Co.,Ltd.
603520.SS
Stockpicker

Video analysis: 603520.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.